Hogne Hallaraker
Founder & Chief Scientific Officer Arctic Bioscience
Experienced Chief Executive Officer with a demonstrated history of working in the biotechnology industry. Strong business development professional skilled in commercializing marine ingredients, Lipid Chemistry, Marine Biology, Pharmaceutical development, Patenting, Clinical documentation and presentation.
Seminars
Wednesday 20th May 2026
Advancing Oral Lipid-Based Therapies in Psoriasis: Overcoming Placebo Barriers & Unlocking Durable Efficacy
12:00 pm
- Advancing a first-in-class oral phospholipid therapy (HRO350) targeting inflammatory resolution pathways in mild-to-moderate psoriasis, offering a non-immunosuppressive alternative with a favourable long-term safety profile
- Demonstrating durable clinical and biological effects through extended follow-up data, highlighting sustained skin improvement and disease control beyond short-term symptom suppression
- Addressing high placebo response as a trial-design consideration by refining endpoint selection, population enrichment, and longitudinal outcome measures to strengthen signal detection in oral psoriasis programs
